Eukaryotic 3′-end formation is a critical step for mRNA maturation and involves a requisite cleavage and polyadenylation event downstream of a polyadenylation signal. Recent discoveries suggest that in nearly 70% of human genes, cleavage and polyadenylation can occur at multiple locations through a process known as alternative polyadenylation (APA). Therefore, APA is a form of co-transcriptional gene regulation that has the potential to greatly expand mRNA transcript diversity. There are two general types of APA. The first includes alternative splicing events (splicing-APA) that result in changes to the coding sequence, and the second does not involve alternative splicing (tandem untranslated region-APA). The latter form of APA occurs within the same terminal exon, thereby only changing the 3′-untranslated region length and content. The role of APA in transformation and cancer is still being deciphered and has been the subject of intensive investigation by multiple groups. Here, we provide a general summary of APA and how it can differentially impact mRNA stability, translation and localization in cis. In addition, we discuss more indirect implications of APA on mRNA transcripts. The latter is based upon the concept that APA can induce the reorganization of both microRNA-mRNA and RNA-binding proteinmRNA interactions. We use these general models as a platform to describe what is known about how tumors manipulate the APA of oncogenes to further drive tumorigenesis. Finally, we briefly discuss the role that next-generation sequencing has played in identifying APA regulators and key transcripts that alter 3′-untranslated region length in cancer.
Introduction
Pre-mRNA maturation includes 3′-end cleavage and polyadenylation, which is critical for the nucleo-cytoplasmic translocation of the transcript, mRNA transcript stability and translation (1) . Typical cleavage and polyadenylation (or mRNA 3′-end formation) are governed by cis-regulatory sequences on the pre-mRNA that are recognized by 3′-end processing factors [cleavage and polyadenylation (CPA) machinery]. The cis-regulatory sequences within the precursor-mRNA may include: a UGUA upstream sequence element (2), auxiliary upstream elements (3) (4) (5) (6) (7) , the hexameric polyadenylation signal (PAS), a GU-/U-rich downstream sequence element and a downstream G-rich sequence (1, 2, 8) . A recent review summarizes the different types of cis-regulatory sequences and their putative location within the pre-mRNA (2) . Some of these sequences are shown together with the 3′-end processing factors that have been experimentally verified to bind to them (Figure 1 ). At its core, the cleavage and polyadenylation complex consists of four multimeric protein complexes, namely, the cleavage and polyadenylation specificity factors (CPSFs), the cleavage stimulation factors (CstFs) and the mammalian cleavage factor complexes I and II (CFIm and CFIIm) (1, 8) . The basic mechanism of cleavage and polyadenylation involves the binding of CPSF30 and Wdr33 to the PAS with the highest affinity for the canonical hexamer AAUAAA while CstF64 binds to the downstream sequence element (9) . These two recognition events likely impact each other similar to how recognition of 3′ and 5′ splice sites coordinate through exon definition (10) . Once these two sites are 'defined', recruitment of other 3′-end processing factors will occur culminating in the assembly of a cleavage and polyadenylation mRNP complex (11) . Cleavage of the pre-mRNA is carried out by CPSF73 and usually occurs ~10-30 nucleotides downstream of the PAS. Addition of 150-300 untemplated adenosines by poly (A) polymerase then follows forming the poly (A) tail that is required for maturation of all eukaryotic mRNAs with the exception of histone coding mRNAs. This process has been extensively reviewed and has been long thought to be a static housekeeping function not subject to regulation (1, 8) .
Initial reports estimated that about one-third of mouse genes and 54% of human genes have more than one PAS (12) . More recent estimates put the number of human genes with multiple PASs closer to 70% (13) . Because normal cleavage occurs downstream of the PAS, the presence of multiple PASs suggests that cleavage and polyadenylation of pre-mRNAs can occur differentially similar to the concept of alternative splicing (14) and has, therefore, been termed alternative polyadenylation (APA). The importance of APA in cellular physiology is only beginning to be understood having been implicated in biological processes ranging from stress response to cellular differentiation. Since that has been reviewed extensively elsewhere (2, 15) , we will restrict this text to the general concept of APA and its role in tumorigenesis.
Implications of APA
The basic premise of APA is relatively straightforward and results in the production of mRNA using distinct poly(A) tail positions that may or may not also differ in coding capacity. The downstream effect of APA is not as easy to predict because altering the length of the mRNA (particularly the 3′-untranslated region [3′-UTR]) may not only directly impact the mRNA itself (e.g. stability, translation, localization) but may also indirectly affect other mRNAs in the cell. Below, we discuss the spectrum of potential cellular consequences in response to APA events.
APA modulates the strength of 3′-UTR destabilizing elements All forms of APA (both splicing-APA and tandem UTR-APA) involve changing the position of the poly(A) tail making the identity of the 3′-UTR different between each mRNA isoform (16) (Figure 2 ). The majority of the 3′-UTR changes are quite likely to be impactful because an estimated 70% of protein-coding genes in humans have conserved microRNA (miRNA) target sites (13, 17) and ~11% have AU-rich elements (AREs) within their 3′-UTRs (18) . Although the function of miRNAs is repressive through recruitment of the RNA-induced silencing complex, AREs can mediate recognition and binding of a repertoire of RNA-binding proteins (RBPs), which, in turn, can negatively or positively regulate both the translation and the stability of the bound mRNA transcripts (19, 20) . Over the past decade, significant attention has been focused on the role that 3′-UTR localized microRNA-binding sites and AREs play in modulating gene expression of protein-coding genes (21, 22 ). It is not surprising then that deregulation of miRNA/ARE-RBPs is associated with many human cancers (23) . Furthermore, at the genomic level, a number of single-nucleotide polymorphisms have been identified that disrupt miRNA-binding sites in the 3′-UTRs of genes associated with increased cancer risk and poor survival (24) .
Tandem UTR-APA provides an alternative/additional way cancer cells can evade regulation by eliminating destabilizing sequence elements within the 3′-UTR (Figure 2 ). The shortening of the 3′-UTR can eliminate both miRNA-binding sites and AREs found in longer 3′-UTRs. The potential impact of this shortening in cancer can be explained by considering how it impacts a proto-oncogene that has two polyadenylation signals within the 3′-UTR. In normal cells, the proto-oncogene uses the PAS most distal to the protein-coding region allowing the resulting transcript to undergo normal regulation by miRNAs and/or RBPs. During transformation, the cell starts using the PAS most proximal to the open reading frame (ORF) generating a short 3′-UTR ( Figure 3 , model 1). This eliminates the miRNA-binding sites making the mRNA resistant to miRNA regulation, hence activating the oncogene. The resulting transcripts with shortened 3′-UTRs are potentially more stable resulting in increased levels of oncogenic proteins facilitating tumorigenicity (21, 22) .
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APA causes redistribution of RBPs and microRNA
Besides the direct effect on the loss of regulatory sequences within the 3′-UTR itself, there are potentially other more indirect effects of APA-driven 3′-UTR shortening during increased cell proliferation and transformation. Shortening of the 3′-UTR may release miRNAs that would have otherwise bound to the longer 3′-UTR isoform (25) . This is also known as the competing endogenous RNA model Figure 3 -model 2). In this case, the longer 3′-UTR acts as an miRNA sponge. Once the miRNA-binding regions are eliminated through shortening of the 3′-UTR through APA, this frees up the miRNAs to act on other mRNA targets in trans. If the newly targeted mRNA encodes a tumor suppressor, binding of the now available miRNAs to its 3′-UTR may inhibit translation/target it for degradation, resulting in decreased protein expression and further support of the oncogenic phenotype. When accompanied with increased expression of the oncogene as a result of its 3′-UTR shortening, this supports the highly proliferative phenotype of tumors (21, 26) . Although this situation seems possible, it has not yet been demonstrated in a robust way in tumors and remains hypothetical. In a related context, the longer 3′-UTR of a gene may also contain numerous sites bound by RBPs. One of the most wellknown RBPs associating with 3′-UTRs binds to the AREs. Some of these RBPs increase mRNA stability [e.g. human antigen R (HuR)], others decrease mRNA stability [e.g. tristetraprolin (TTP)] and others, like AUF1, have been reported to do both (27) . In the context of cancer, if the longer 3′-UTR of a gene has sequences that are bound by RBPs that enhance its stability, then shortening of the 3′-UTR and elimination of these sequences through APA will result in the destabilization of the shorter transcript resulting in reduced protein expression (Figure 3-model 3) . In this 'RBP reorganization model', the RBPs are now free to bind to other 3′-UTRs more effectively and may modulate mRNA stability of those mRNAs. A complicating factor that must also be considered is that miRNAs and RBPs have the potential to compete for binding within the 3′-UTR of a single mRNA transcript. If the miRNA binds, then the message is destabilized resulting in decreased protein translation. Alternatively, if RBPs are more abundant than the miRNAs then they will more often associate with a 3′-UTR and the RBP binding could restructure the transcript, preventing access of miRNAs, resulting in increased translation. This has been observed for the coding region determinant-binding protein, which was found to compete with miRNAs for 3′-UTR-binding sites in cancer (28) . Alternatively, binding of a particular set of RBPs could also restructure the target mRNA, making it more accessible to certain miRNAs.
Finally, recent studies suggest that on a global scale, the truncation of the 3′-UTR of genes involved in anti-proliferative or pro-differentiation pathways actually enhances their repression by miRNAs (29) . These findings are based on the premise that the spatial location of miRNA-binding sites within the 3′-UTR affects both miRNA targeting and its efficacy. Specifically, miRNA target sites located in the middle portion of the 3′-UTR are considered less impactful, resulting in little repression when bound by their miRNAs. However, APA shortening the 3′-UTRs brings these previously centrally localized miRNA-binding sites to the ends of the mRNA. When miRNAs bind to these now truncated 3′-UTRs so that they are now positioned closer to the poly(A) tail, their potency is increased, which results in the repression of these tumor suppressive genes (29, 30) .
APA can alter mRNA and protein localization
The identification of two distinct brain-derived neutrophenic factor transcripts whose only difference is in their 3′-UTRs provides significant insight into another possible implication of APA. In the brain, the truncated 3′-UTR brain-derived neutrophenic factor transcript localized to the soma while the longer 3′-UTR containing transcript is found in dendrites ( Figure 3 , model 4), implying that the two isoforms may have different physiological functions due to differences in their specific subcellular localization (31) . This observation has recently been extended to a more global scale as it has been reported that, in general, longer 3′-UTR isoforms localize to neurites at a four-fold rate greater than the shorter 3′-UTR isoforms of the same genes. This spatial separation of distinct 3′-UTR transcripts allows differential site-specific synthesis of protein (32) .
Independent of mRNA transcript localization, APA-derived 3′-UTRs have also been proposed to have an impact on the localization of the actual encoded protein. The mechanism involves the binding of RBPs to the 3′-UTR of the longer isoform, but not the shorter 3′-UTR isoform, and mediates translocation of the long 3'UTR transcripts to the cell membrane resulting in enhanced expression at the cell surface. This has been shown for several transmembrane proteins, i.e. CD44, ITGA1, TSPAN13, TNFRSF13C and the Integrin Associated Protein also known as CD47 (33) . For CD47, the long 3′-UTR mRNA acts as a scaffold that recruits the RBP HuR (ELAV1) localization factors that direct the long 3′-UTR CD47 isoform-derived protein through vesicles to the plasma membrane after its translation in the endoplasmic reticulum. However, although the shorter 3′-UTR CD47 mRNA transcript is also translated in the same endoplasmic reticulum, its encoded protein does not localize to the cell membrane (33) . The actual role tandem UTR-APA plays in regulating transmembrane localization and or mRNA transcript subcellular localization of cancerspecific genes is still unknown.
Effect of APA on well-known oncogenes during tumorigenesis
It is important to consider that not all oncogenes are subject to APA as not all transcripts contain more than one polyadenylation signal. Moreover, it is equally important to understand that if an oncogene undergoes APA then it does not necessarily translate to greater expression or increased mRNA stability. The benefit of 3′-UTR shortening is only realized in a cell type if there is significant expression of microRNA targeting the oncogene's 3′-UTR or sufficient expression of negative regulating RBPs is occurring. In other words, 3′-UTR shortening should be considered as a 'de-repression' mechanism rather than activation. Next, we provide description of several defined oncogenes that have been found to undergo APA in tumors.
D-type cyclins
The most well-characterized and known oncogenic role of the G 1 -cyclin, cyclin D is in promoting cell proliferation. In this classical model, cyclin D binds to the cyclin-dependent kinases 4 and 6. The resulting complex then hyper-phosphorylates the retinoblastoma protein, hence uncoupling it from E2F transcription factors. This allows activation of the E2F transcription factors and allows for the expression of genes that are required for DNA synthesis and G 1 to S-phase transition (34, 35) .
One of the most well-known examples of APA with both pathophysiological and clinical relevance is the truncation of the 3′-UTR of cyclin D1 in Non-Hodgkin's, Mantle cell lymphoma (36, 37) . In this case, despite having the same ORF, tumors that expressed the isoform with the truncated 3′-UTR have higher levels of cyclin D1 mRNA transcripts and have higher proliferation rates, which are associated with shorter survival (37) . Some of these truncations were hypothesized to be due to uncharacterized genomic deletions of the 3′-UTR. However, several Mantle cell lymphoma patient samples and cell lines reveal mutations within the 3′-UTR at positions proximal to the stop codon, resulting in the creation of a canonical PAS (AAUAAA). The resulting cleavage and polyadenylation from this mutated site creates cyclin D1 transcripts lacking ~3 kb of the 3′-UTR that normally comprises ~3.5 kb of the length of the full ~4.3 kb cyclin D1 transcript (37) . Mantle cell lymphoma cell lines containing the truncated cyclin D1 3′-UTR expressed more cyclin D1 protein and had a higher percentage of cells in the S-phase of the cell cycle (22, 37) . Reporter assays, where the truncated cyclin D1 3′-UTR was cloned downstream of luciferase showed that truncation of the 3′-UTR results in evasion of miRNA (miR-16-1, miR-15 and miR17/20a) regulation due to elimination of the target miRNA-binding sites found within the longer cyclin D1 3′-UTR transcripts (21, 22, 38) . Mutation of the putative miRNA 'seed regions' also had similar effects (22, 38) . In addition, northern blot analysis after actinomcycin D treatment shows that the truncated cyclin D1 transcript was more stable than the fulllength 3′-UTR transcript (21) .
Similar to cyclin D1, the truncated isoform of cyclin D2 also demonstrates increased protein expression and stability compared with the full-length isoform (21) . In a clear demonstration of the importance of APA to the cyclin D2 transcript, it was found that transfection the cyclin D2 ORF containing either the truncated or full length 3′-UTR into cyclin D2 null MCF7 breast cancer cells more cells present in the S-phase of the cell cycle due to the short isoform compared with the longer transcript (21) . Hence similar to cyclin D1, cyclin D2 APA resulting in a truncated 3′-UTR is important in regulating cell proliferation.
Cell division cycle 6
The cell division cycle 6 (CDC6) (39) plays an essential role in regulating the initiation of DNA replication and is rate limiting for S-phase entry (40) . In cancer cells, RNAi depletion of CDC6 inhibits cell proliferation and induces apoptosis (41) . Overexpression of CDC6 in human cancers results in repression of the INK4/ARF locus inhibiting the expression of the tumor suppressor genes p15
INK4b
, ARF and p16
INK4a (42) . When Akman et al. treated estrogen receptor positive breast cancer cells with estrogen (17β-estradiol), this resulted in shortening of the 3′-UTR of CDC6. The switch from using the more distal PAS and using the proximal PAS resulted in a shorter mRNA isoform that was refractory to miRNA regulation. This resulted in elevated protein expression as shown by western blot. Increased BrdU incorporation suggested that the truncated isoform played a role in cell proliferation (43) . These results indicate that CDC6 is not only subject to APA regulation but there is an estrogen-dependent signaling pathway responsible for regulating expression of the short and long isoform in breast cells.
Insulin-like growth factor 2 mRNA-binding protein 1
Originally discovered as the mRNA-binding protein that binds to β-actin mRNA, the insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1/IMP-1), also known as coding region determinant-binding protein, has been implicated in binding to and shielding a number of other mRNAs, including c-myc, from endoribonucleolytic cleavage (44) . The stabilization of c-myc mRNA and that of other oncogenic genes has important implications in cancer (45, 46) . Upregulated levels of IMP-1 have been observed in primary human colorectal tumors, where it is associated with inhibition of apoptosis through activation of the Nuclear Factor Kappa B Subunit 1 (NF-κB) transcription factor (46) . IMP-1 has also been found to be upregulated in several other human cancer tissues (47) . Its role in cell migration also posits it as a major player in metastasis (48) . Because the IMP-1 3′-UTR makes up ~75% of the total mRNA, it is a perfect model target for miRNA regulation (21) .
The IMP-1 mRNA displays four distinct isoforms as assessed by northern blot, and 3′-RACE confirms that indeed these are the result of different polyadenylation signals, all located within the same exon. Placement of the full IMP-1 6.3 kb 3′-UTR (6.3 kb) downstream of a luciferase reporter gene has a 4-fold reduction in luciferase activity, suggesting reduced protein synthesis when compared with the shorter IMP-1 isoform (369-nt 3′-UTR). In addition, the truncated IMP-1 isoform's half-life is double that of the full-length 3′-UTR isoform, indicating increased stability due to the loss of miRNA target sites. For further validation, transfection with retroviral vectors containing the IMP-1 ORF with the truncated 3′-UTR resulted in increased protein levels and soft-agar assays resulted in more colonies being formed with the expression of the shorter isoform compared with IMP-1 expressing the full-length 3′-UTR. The oncogenic potential of the truncated IMP-1 isoform was further validated by its ability to transform NIH3T3 fibroblasts and human breast epithelial cell lines (HMLE and MCF10A) (21) . These results provide a clear link between truncation of the IMP-1 3′-UTR and cellular transformation. Considering the role that IMP-1 plays by binding mRNAs and recruiting transcripts to target transcripts to cytoplasmic protein-RNA complexes (mRNPs), hence shielding them from endonucleases and miRNA-mediated degradation, its overexpression through APA may have even more far reaching effects in tumor biology.
High-mobility group AT-hook 2
The major non-histone protein high-mobility group AT-hook 2 (HMGA2) is an architectural transcription factor that binds DNA and alters the chromatin architecture (49, 50) . HMGA2 is normally expressed during embryogenesis when cells are highly proliferative and is not present in terminally differentiated tissue. However, the protein becomes overexpressed in several types of cancer, including benign tumors of mesenchymal origin and malignant human neoplasias including non-small cell carcinoma of the lung (50, 51) . Its expression levels are highly correlated with its metastatic potential, degree of malignancy and survival (52) (53) (54) . As an architectural transcription factor, HMGA2 has a myriad of cellular functions, including gene regulation and the cell cycle (49, 50) . Previous studies showed that HMGA2 is involved in cell growth since wild-type embryonic fibroblasts grew faster than HMGA2 deficient. In addition, HMG2 null mice exhibited decreased growth and had the pygmy phenotype (55) . This suggests that in addition to other roles, HMGA2 protein overexpression results in increased cell proliferation.
In some types of tumors (e.g. uterine leiomyoma and pulmonary chondroid hamartomas), there are chromosomal translocations that result in a truncated HMGA2 ORF that result in its overexpression (56) . However, in several other cases, the translocations leave the ORF unaltered but cause the 3′-UTR to become either truncated or eliminated, resulting in increased HMGA2 protein overexpression. The HMGA2 3′-UTR contains several conserved let-7 miRNA target sites and the translocations that eliminate the 3′-UTR result in miRNAs that are refractory to let-7 miRNA regulation (31, 57) . Stable H1299 lung cancer cell lines that express the full HMGA2 ORF, but lack the 3′-UTR, are indeed observed to be resistant to let-7 miRNA regulation. These cells have a greater cell growth when transfected with let-7 duplex compared with cells expressing HMGA2 with an intact 3′-UTR (31).
Cyclooxygenase-2
Cyclooxygenase (COX) (prostaglandin H 2 synthases) enzymes are rate-limiting enzymes that convert free arachidonic acid into prostaglandin H 2 . Prostaglandins, in turn, are involved in a variety of physiological processes (58) . There are two COX isoforms, COX1 and COX-2. COX-1 is the form that is constitutively expressed in most tissues. Aberrant and chronically high levels of COX-2 are found in human colorectal tumors and other types of cancer (58, 59) . In a mouse model of human familial adenomatous polyposis, COX-2 null mice have smaller and a reduced number of intestinal polyps compared with mice expressing COX-2 (60). Hence, unregulated expression of COX-2 is believed to be integral in the development of colorectal cancer (58) .
There are two major COX-2 mRNA transcripts that have been identified. They both contain the intact COX-2 ORF but differ in their 3′-UTRs. The smaller transcript is ~2.8kb and is generated from a proximal non-canonical polyadenylation signal (AUUAAA). The larger transcript (~4.6 kb) is as a result of processing from the more distal canonical PAS signal AAUAAA (61) . When the smaller transcript is expressed in colorectal cancer, it was shown to be more stable than the longer transcript. This truncated transcript was initially found in a colon cancer cell line HCA-7 and has since been observed in numerous other tissues (61, 62) . The predominant destabilizing elements identified in the COX-2 full-length 3′-UTR are an AU-rich region, which contain about six repeats of the AUUUA pentamer. This ARE confers instability to COX-2 and other immediate early response transcripts. The COX-2 ARE is bound by the RNA-binding Zn finger protein TTP, which facilitates its rapid decay and in transformed intestinal epithelial cells, the halflife of the full transcript was ~13 minutes. A reporter gene containing the truncated 3′-UTR had increased expression, and the mRNAs had enhanced stability. The shorter transcript escapes this rapid decay because it lacks the TTP-binding sites and hence it is not subject to TTP-mediated downregulation (62) .
Another RBP that also binds the ARE of COX-2 is HuR (HuR/ELAVL1). HuR antagonizes the activity of TTP, and when bound to the ARE, it results in increased COX-2 stability and translation (63). HuR's mechanism of action involves regulation of miR-16 binding to the 3′-UTR of COX-2. There are two putative miR-16-binding sites in close proximity with the ARE within the long 3′-UTR of COX-2. When HeLa cells that were stimulated to express COX-2 were transfected with miR-16, endogenous COX-2 mRNA was quickly degraded. This was verified with luciferase reporters containing the fulllength 3'UTR of COX-2. Further studies showed that untransformed cells express low levels of HuR, which localized to the nucleus allowing miR-16 to bind to the 3'UTR of COX-2 facilitating its degradation. In contrast, cancer cells overexpress HuR, which localizes to the cytoplasm where it downregulates miR-16, hence interfering with miR-16 regulation of the COX-2 3'UTR (64).
Human antigen R
Interestingly, the RBP HuR itself also undergoes APA (65) . HuR is overexpressed in several tumors, including adenomas and adenocarcinomas of colorectal and colon cancers (63) . The HuR 3′-UTR contains three polyadenylation signals which gives rise to three mRNAs which only differ in their 3′-UTR length (1.5, 2.7 and 6 kb) and content (65, 66) . The 6kb transcript that contains a distal ARE is rare while the 2.7 kb transcript with the shorter 3′-UTR that lacks the ARE is the most abundant. Reporter assays of the different 3′-UTRs fused to EGFP showed decreased stability of the longer HuR that contains the ARE transcript (65) . The shorter 2.7 kb variant is overexpressed in breast cancer when compared with normal tissues (66) . Hence, in HuR, the ARE plays a major role in destabilizing the longer 3'UTR transcript resulting in its degradation and low expression level in tumors.
Regulators of APA
Because APA is a form of post-transcriptional gene regulation that offers a mechanism of proto-oncogene activation independent of known genetic or epigenetic causes, understanding how it is regulated is critical. As stated in the introduction, the sequence of the PAS and the surrounding cis elements on the pre-mRNA play an important role in determining the cleavage site of the pre-mRNA (Figure 1 ). The optimal PAS sequence is AAUAAA and this sequence is frequently found at a site more distal to the stop codon while non-canonical PAS hexameric sequences occur at a site more proximal to the stop codon (67) . Furthermore, optimal cleavage of the premRNA occurs after the CA dinucleotide and the presence or absence of this site may impact whether or not a given PAS is used. Finally, the actual PAS selected is not only determined by the PAS sequence and cleavage site but is also determined by the presence of other cis elements, including the downstream sequence elements (G/U and U rich) or upstream sequence elements (U rich/UGUA sequences). Taken as a whole, the collective consensus of all of these cis elements contribute to an overall likelihood as to whether or not a PAS is chosen in a given cell type.
In addition to the cis elements, factors that can bind to the pre-mRNA could potentially play a role in regulating APA. Although APA is often presented as an independent process, in vivo, 3′-end formation (including APA), is closely linked to transcription and splicing. As such, factors that affect transcriptional rate e.g. Pol II pausing, levels of transcription factors, splicing factors and factors involved in 3′-end formation may have an impact on APA. The role of most of these factors in facilitating tumorigenesis as a result of their effects on APA regulation is still not completely understood but examples of some potential key regulators have been found.
Members of the CPA machinery as APA regulators
So far, the majority of protein factors that have been identified as regulators of APA are the general factors that are involved in constitutive cleavage and polyadenylation (Figure 1 ). These factors constitute what is also known as the CPA machinery. This parallels what has been observed in splicing where several general splicing factors have also been shown to play a role in alternative splicing. Some of these general factors have been shown to regulate APA of specific set of genes while others have a more global effect on APA. Here we will focus on a subset of these factors that have been experimentally validated to regulate APA.
CstF64 was the first 3′-end processing factor identified in playing a role in regulating APA of immunoglobulin M in activated mouse B-cells (68) . High levels of CstF64 resulted in the selection and use of a weaker proximal PAS, resulting in the generation of a transcript that was translated to produce a secreted immunoglobulin M protein. Conversely, lower levels of CstF64 favored selection of the more distal and canonical PAS resulting in the synthesis of membrane bound immunoglobulin M protein (68) . On a global scale, simultaneous depletion of CstF64 and its paralog CstF64τ resulted in a transcriptome-wide switch to a more distal PAS, resulting in the generation of transcripts with longer 3′-UTRs (69) . In what seems to be an opposing activity to CstF64, members of the mammalian cleavage factor I (CFIm) complex (namely CFIm25 and CFIm68) have been shown to play a major role in regulating APA at both the individual gene level and on a more global scale. In particular, depletion of CFIm25 results in a global 3′-UTR shortening in human cells (26, (70) (71) (72) . In a mouse xenograft model of glioblastoma, low levels of CFIm25 were linked to increased tumorigenesis and tumor growth (26) . Down regulation of Pcf11, a member of the mammalian cleavage factor II (CFIIm) complex, results in broad lengthening of the 3′-UTRs in C2C12 mouse cells. Loss of yet another Fip1 in the same cell line had similar effects (73) . Fip1 was also shown to regulate APA in mouse embryonic stem cells. Knockdown of Fip1 resulted in APA to the distal PAS in most genes, resulting in increased 3′-UTR length. Several of these were self-renewal factors (74) . Mutations in individual CPA machinery members have not been observed to play a significant role in cancer predisposition but are likely to be altered in expression levels as tumors progress, thereby allowing plasticity in 3′-UTR usage for tumor adaptation.
Non-CPA proteins that regulate APA
In addition to 3′-end processing factors, several other factors have also been implicated in regulating APA in cancer. One of these factors is the transcription factor E2F. Depletion of E2F resulted in global shortening of the 3′-UTRs. The effect of E2F may be indirect, with effects on the expression of the 3′-end processing factors as many of the factors have E2F-binding sites in their promoters (75) . Depletion of the retinoblastomabinding protein 6 resulted in widespread lengthening of the 3′-UTR, which was accompanied by decreased levels of AU-rich 3′-UTR transcripts. Retinoblastoma-binding protein 6 can bind to the 3′-end processing machinery (CPA), and thus regulate APA (76) . Depletion of the nuclear poly (A)-binding protein facilitates global 3′-UTR shortening (77) . Knockingdown the other PABP, PABPC1 had similar effects (73) . The endoribonuclease DICER1 also results in increased proximal PAS site usage, upon its knockdown (78) . In contrast, the presence of the cytoplasmic polyadenylation element-binding protein 1, which has been shown to shuttle to the nucleus, promotes the generation of shorter 3′-UTRs. Knockingdown cytoplasmic polyadenylation element-binding protein 1 has the opposite effect, facilitating the generation of longer 3′-UTRs (79) . Splicing factors can also regulate APA through a process called 'telescripting'. Depletion of U1 small nuclear ribonucleoprotein resulted in premature cleavage and polyadenylation of pre-mRNA using cryptic intronic PASs and the inability to transcribe full-length pre-mRNA transcripts (80) . Moderate levels of U1 small nuclear ribonucleoprotein 1 resulted in global increase in 3′-UTR shortening in a dose-dependent manner (81) . We have summarized these and other currently known regulators of APA that were experimentally validated in human cells/tissues ( Table 1 ). The physiological relevance or link to cancer for APA regulated by most of these factors is still unknown.
The utility of genome-wide analysis in understanding the importance of APA to tumorigenesis Most of the oncogenes identified above as undergoing APA were identified in the absence of next-generation sequencing technology, one gene at a time. Initial studies of changes in global APA involved the use of microarrays, which have several wellknown limitations. These include lack of sensitivity (for genes expressed at low or very high levels), limited dynamic range and possible competitive cross-hybridization. In addition, the design and location of the probes limited APA analysis because it was dependent on previously annotated polyadenylation sites and could not identify novel sites (82) (83) (84) .
Since then, recently developed next-generation sequencing technologies utilized portioned variations of RNA-seq to enrich for poly(A) sites have resulted in the detection of both known and novel APA events in mammalian cells (26, 75, 85, 86) . Genome-wide analyses have revealed that, indeed, there are widespread changes in APA in cancer cells, and in general, there is preferential global truncation of 3′-UTR isoforms in cancer cells and tissues (26, 75, 87) . A particular study with diagnostic potential used probe-level microarrays targeting the 3′-UTR to develop molecular signatures to identify and classify otherwise indistinguishable tumor subtypes with different survival outcomes with a high degree of accuracy (87) . One of the largest studies to date used 358 sets of paired normal and tumor RNA Seq data from the Cancer Genome Atlas (TCGA) database across seven tumor types. It identified recurrent APA changes in ~1350 genes. The detected APA changes in this study were also tumorspecific and can potentially be used as biomarkers (88) . So far, APA resulting in truncated transcripts has been associated with increased cellular proliferation, cellular transformation and enhanced metastasis (21, 22, 26, 75, 89, 90) . We envision that further next-generation sequencing analyses of human tumors cross-referenced with patient diagnostic data present in the TCGA database will establish a true 'APA signature' within tumors that may have prognostic value.
Conclusion
It is clear from the examples of oncogenes given in this review that in spite of the large number of genes identified in literature as undergoing shortening in proliferative and transformed states, very few genes have been experimentally validated in the laboratory to result in increased protein expression. This suggests that the traditional role of APA enhancing mRNA stability and increasing protein expression may apply to only a subset of genes, perhaps oncogenes. For the other genes, APA may play other roles including directing subcellular specific localized translation or recruitment of proteins to enable eventual localization of the translated protein. The link of these roles and their contribution to cancer remains to be determined.
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